Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced ...

This includes the likes of Ozempic, Mounjaro, Saxenda and Wegovy, which can sell for up to £269 a month. The drugs have proved popular with overweight Brits who want to rapidly lose weight and ...

John Fetterman (D-Pa.) on Wednesday called on the Trump administration to back a Biden-era rule that would expand access to GLP-1 medications, such as Ozempic and Wegovy, for millions of Medicare ...

The rise of weight-loss drugs like Ozempic and Wegovy have upended WeightWatchers business model, which was based around selling low-calorie foods and diet advice to overweight people.

The use of drugs like Ozempic, Wegovy and Zepbound in people with type 1 diabetes has risen sharply over the past decade, a new study finds, even though there’s little information on the drugs ...

This was a mistake. These drugs, like Ozempic and Wegovy, can be a game changer.” Fetterman says he has lost 20 pounds and is not being paid for discussing his treatment. “I’m just a guy who ...

In this exclusive interview, Business Today speaks with Vikrant Shrotriya, Managing Director of Novo Nordisk India, about the significance of semaglutide (the active ingredient in Wegovy), its ...

“This was a mistake.” Fetterman made it clear that he was not receiving any money for his opinion, and wrote that he believes drugs like Mounjaro, Ozempic and Wegovy are a “game changer.

Novo Nordisk is preparing to launch its blockbuster obesity drug Wegovy (injectable semaglutide) in India later this year, the company told Business Today, setting the stage for a high-stakes ...

Abbott signs Texas DOGE bill Big Changes Are Coming To KFC In 2025 FDA stops sale of generic versions of Ozempic and Wegovy: What it means for patients See the first new dire wolf cubs born in ...

The most popular GLP-1 agent today is semaglutide, the active ingredient in type 2 diabetes medication Ozempic and the higher-dose obesity drug Wegovy. Semaglutide and newer GLP-1 drugs help ...

They said that semaglutide, which is sold under the brand names Ozempic and Wegovy, was “statistically significantly associated with a decreased risk” of dementia. Semaglutide was initially ...